PALO ALTO, Calif.--(BUSINESS WIRE)--July 29, 2005--StemCells, Inc. (NASDAQ: STEM) today reported its financial results for the second quarter ended June 30, 2005. The Company reported a net loss...
PALO ALTO, Calif.--(BUSINESS WIRE)--July 6, 2005--StemCells, Inc. (NASDAQ: STEM) announced today that it has entered into an agreement with ReNeuron, a privately-owned UK biotech corporation. The...
PALO ALTO, Calif.--(BUSINESS WIRE)--June 29, 2005--StemCells, Inc. (NASDAQ: STEM) today announced its inclusion in the Russell 3000(R) Index. The Russell 3000 Index measures the performance of the...
Form 8-K for STEMCELLS INC
--------------------------------------------------------------------------------
11-Jan-2005
Other Events, Financial Statements and Exhibits
ITEM 8.01...
CHICAGO, Jan 4 (Reuters) - StemCells Inc. (STEM.O: Quote, Profile, Research) on Tuesday said it plans to start an early-stage clinical trial using brain stem cells to treat Batten disease, a rare...